Company Active LTD

Company profile

Imspex Diagnostics Limited

Home | Imspex Group

The power of chemistry combined with data analysis. At your fingertips. Pioneers in GC-IMS technology Delivering fast, accurate, lab-quality analysis on-lin ...

CRN
07533570
Founded
2011
Age
15

Overview

Legal name
IMSPEX DIAGNOSTICS LIMITED
Region
Wales
Registered address
TY MENTER
NAVIGATION PARK
ABERCYNON
RCT
CF45 4SN
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Imspex Diagnostics Limited
No active corporate controller recorded.

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
£3,789,114
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

9 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

06 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

23 Oct
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

06 Nov
2024

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzQ0MjE5MDA2M2FkaXF6a2N4

Published 06 Nov 2024 10:37

05 Nov
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MjAxODQxN2FkaXF6a2N4

Published 05 Nov 2024 10:15

31 Oct
2024

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzQ0MTQzMjgyNmFkaXF6a2N4

Published 31 Oct 2024 10:17

09 Aug
2024

Accounts With Accounts Type Full

Accounts Analysed

AA | Transaction MzQzMTcxMTc2N2FkaXF6a2N4

Published 09 Aug 2024 10:36

17 Feb
2011

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2017
Funded years
2017, 2020, 2021, 2022
Age at first award
6 years

Projects

2022 EU-Funded Lead participant

ONELAB

1 Oct 2022 to 30 Sep 2025

Awarded
£86,908
Total cost £124,154

no public description

2022 Collaborative R&D Lead participant

Comparability of Breathspec for Breath Analysis

1 Jan 2022 to 31 Mar 2022

Awarded
£11,233
Total cost £11,233

IMSPEX provides a range of analytical devices to different sectors to help with health, environmental and industrial problems. Our mission is to bring laboratory quality analytical capabilities out of the laboratory and to the point of need. The simplicity and speed of analysis of the technology, known as GC-IMS, is ideally placed to allow those in need o...

2021 Collaborative R&D Lead participant

Fighting Antibiotic resistance with point of care breath analysis

1 Dec 2021 to 31 Jan 2022

Awarded
£100,000
Total cost £100,000

Due to the over prescription of antibiotics in cases where they do not help people get better, some bacteria have become resistant to them. To slow down this resistance, doctors need to prescribe less antibiotics in cases where they will not help. One way to do this is by developing a test to detect if a patient has a bacterial infection or not. This test...

2020 Study Lead participant

Early Detection of Biocontamination by Fast GC/IMS

1 Nov 2020 to 31 Jan 2023

Awarded
£106,581
Total cost £177,635

Biocides are used to control harmful and unwanted organisms and microorganisms and are used in many manufacturing processes to reduce the risk of bio-contamination in products. This can have a negative effect on the environment and so in the future here will be less and less biocides used. Although good news for the environment, manufacturers are finding ...

2020 Study Lead participant

Fighting Antibiotic Resistance with Point of Care Breath Analysis

1 Aug 2020 to 30 Apr 2022

Awarded
£210,461
Total cost £350,767

Due to the over prescription of antibiotics in cases where they do not help people get better, some bacteria have become resistant to them. To slow down this resistance, doctors need to prescribe less antibiotics in cases where they will not help. One way to do this is by developing a test to detect if a patient has a bacterial infection or not. This test...

2017 Feasibility Studies Lead participant

Determination of Palm Oil Sustainability and Traceability using GC-IMS

1 Nov 2017 to 31 Oct 2018

Awarded
£49,912
Total cost £83,186

Palm oil is used in many food and cosmetic products by companies such as Cadbury, Nestle and Unilever, however palm oil production is currently not very sustainable and many forests are being cut down to plant new trees for the growing global demand of palm oil. These companies and the European parliament want to make palm oil more sustainable and ensure ...

2017 Feasibility Studies Lead participant

Rapid point of care test for Group B streptococcus in late pregnancy and onset of labour

1 Aug 2017 to 31 Jul 2018

Awarded
£69,673
Total cost £116,122

GBS is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is not harmful to you, however, many babies come into contact with GBS during labour. The vast majority of babies will suffer no ill effects. However, if GBS is passed from mother to baby at time of the birth, there is a small chance the baby will develop an in...

Product types

Collaborative R&D EU-Funded Feasibility Studies Study